Centrexion Therapeutics

View the org chart displaying its 12 main executives

Most searched biographies at Centrexion Therapeutics

• Jeffrey Kindler, Chief Executive Officer and Director
• Shawn Tomasello, Director
• J.C Lopez, Director

Create your alert
to follow the executive moves at Centrexion Therapeutics.

Centrexion Therapeutics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Centrexion Therapeutics

Social media about Centrexion Therapeutics

• Centrexion Therapeutics on Wikipedia, Google News & Yahoo Finance
• Centrexion Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Jeffrey Kindler

Call Centrexion Therapeutics at +1 617...

View the org chart

Register to receive your alert

Report an error